We are testing a new treatment for patients with advanced NSCLC who have mutations in the EGFR and/or HER2 genes. This study aims to explore its effects on cancer progression.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced Non-Small Cell Lung Cancer (NSCLC) is a type of lung cancer that has spread beyond the lungs to other parts of the body, making it more difficult to treat. It is the most common form of lung cancer and can cause serious health issues.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
